Ltr Pharma LimitedASX: LTP

SPONTAN Phase II data show rapid onset, support FDA pathway

May 1, 2026 at 3:39 AM UTC

Ltr Pharma Limited has released a press release.

View Attachment

Earlier from Ltr Pharma

SPONTAN Phase II Clinical Study Completes RecruitmentMar 5

All Ltr Pharma news releases